Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Transcatheter Aortic Valve Replacement	4.14B	4.11B	4.05B	3.99B	3.94B	3.88B	3.77B	3.67B
Transcatheter Aortic Valve Replacement Growth	5.20%	5.83%	7.46%	8.65%	9.90%	10.28%	6.99%	4.32%
Surgical Structural Heard	966.10M	981.30M	1.02B	1.03B	1.02B	999.30M	975.20M	948.30M
Surgical Structural Heard Growth	-5.02%	-1.80%	4.45%	8.11%	10.51%	11.89%	9.54%	6.79%
Transcatheter Mitral and Tricuspid Therapies	394.40M	352.10M	303.00M	264.30M	228.90M	197.60M	173.10M	150.40M
Transcatheter Mitral and Tricuspid Therapies Growth	72.30%	78.19%	75.04%	75.73%	75.13%	70.20%	57.51%	46.73%
Critical Care	-	-	-	-	957.50M	928.10M	902.60M	888.90M
Critical Care Growth	-	-	-	-	10.72%	8.55%	7.25%	4.95%

Revenue by Geography

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
United States	3.10B	3.21B	3.46B	3.52B	3.60B	3.51B	3.41B	3.33B
United States Growth	-13.78%	-8.63%	1.37%	5.86%	11.39%	12.01%	10.83%	9.32%
Europe	1.30B	1.32B	1.37B	1.37B	1.37B	1.33B	1.28B	1.23B
Europe Growth	-5.51%	-0.96%	6.85%	11.59%	14.76%	13.59%	7.29%	1.14%
Rest of World	543.30M	572.00M	656.40M	688.10M	722.80M	709.20M	677.30M	655.00M
Rest of World Growth	-24.83%	-19.35%	-3.09%	5.05%	16.28%	17.92%	14.33%	14.03%
Japan	310.80M	339.80M	391.60M	418.60M	449.10M	452.40M	451.50M	447.20M
Japan Growth	-30.79%	-24.89%	-13.27%	-6.40%	-0.69%	-4.48%	-9.95%	-14.53%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.